Sage Therapeutics, Inc. (SAGE)
Cambridge, MA
Total Compensation for Fiscal Year Ending in 2024: $7,112,589
| Salary | $830,712 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $3,164,364 |
| Value of Option Awards | $2,669,263 |
| Non-Equity Incentive Plan Compensation | $431,970 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $16,280 |
| Total | $7,112,589 |
Sage Therapeutics, Inc. disclosed its CEO pay was
22
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?